Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Predicting short-term conversion from CIS to MS: Relevance of lesion distribution.
Clinical testing for neutralizing antibodies to interferon-β in multiple sclerosis.
Designed Glucopeptides Mimetics of Myelin Protein Epitopes As Synthetic Probes for the Detection of Autoantibodies, Biomarkers of Multiple Sclerosis.
Toxoplasmosis and Polygenic Disease Susceptibility Genes: Extensive Toxoplasma gondii Host/Pathogen Interactome Enrichment in Nine Psychiatric or Neurological Disorders.
Evaluation of Study and Patient Characteristics of Clinical Studies in Primary Progressive Multiple Sclerosis: A Systematic Review.
SEMA4D compromises blood-brain barrier, activates microglia, and inhibits remyelination in neurodegenerative disease.
[Contrast agents in MRI-diagnosis of multiple sclerosis].
Current and emerging therapies in multiple sclerosis: a systematic review.
Fluctuations of MS births and UV-light exposure.
A 10-year follow-up of a population-based study of people with multiple sclerosis in Stockholm, Sweden: Changes in health-related quality of life and the value of different factors in predicting health-related quality of life.
Paroxysmal chorea as a relapse of myelopathy in a patient with neuromyelitis optica.
Microglia: The constant gardeners.
FDA Approves New Drug to Treat Psoriasis
Chromosomal radiosensitivity in patients with multiple sclerosis.
Epithelial v-like antigen mediates efficacy of anti-alpha4 integrin treatment in a mouse model of multiple sclerosis.
Attenuation of corpus callosum axon myelination and remyelination in the absence of circulating sex hormones.
Using the random forest method to detect a response shift in the quality of life of multiple sclerosis patients: a cohort study.
Cerebrospinal fluid and urinary biomarkers in multiple sclerosis.
Comparison of the 2010 and 2005 versions of the McDonald MRI criteria for dissemination-in-time in Taiwanese patients with classic multiple sclerosis.
Amyloid fibril formation and chaperone-like activity of peptides from alphaA-crystallin.
Medical and Nonstroke Neurologic Causes of Acute, Continuous Vestibular Symptoms.
In vivo imaging of activated microglia in a mouse model of focal cerebral ischemia by two-photon microscopy.
Enhanced Neuroprotective Effects of Combination Therapy with Bone Marrow-Derived Mesenchymal Stem Cells and Ginkgo biloba Extract (EGb761) in a Rat Model of Experimental Autoimmune Encephalomyelitis.
On the contribution of Thomas Clifford Allbutt, F.R.S., to the early history of neuromyelitis optica.
Pathogenesis of multiple sclerosis: what can we learn from the cuprizone model.
Pages
« first
‹ previous
…
275
276
277
278
279
280
281
282
283
…
next ›
last »